
Abbott Laboratories' (NYSE: ABT) share price corrected by approximately 45% from peak to trough, bottoming in early Q2 2026 after reaching incredibly oversold levels.

Abbott Laboratories' (NYSE: ABT) share price corrected by approximately 45% from peak to trough, bottoming in early Q2 2026 after reaching incredibly oversold levels.